Drug Development through Modeling and Simulation – the Business Case
The new blockbuster: well-defined patient populations bring efficiency to drug development and higher commercial value to precision drugs (labels).
The new blockbuster: well-defined patient populations bring efficiency to drug development and higher commercial value to precision drugs (labels).
PRINCETON, NJ – Sept. 22, 2016 – Certara today announced that the first Certara Biomedical Research Scholarship has been awarded to the National Institutes of Health (NIH) National Center for Advancing Translational Science (NCATS) on behalf of postgraduate oncology research student David Morse, MPhil, and the research he is conducting in the laboratory of Craig Thomas, PhD.
Scientists at the Aarhus University in Denmark used the Simcyp Simulator to support a forensic toxicological assessment of a fatal drug poisoning case.